NPCE NeuroPace
- 9.090
- +0.090+1.00%
NeuroPace News
NeuroPace | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(11.7%),OrbiMed Capital GP VI LLC(11.7%)
NeuroPace | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Management, L.P.(8.2%),Soleus GP, LLC(8.2%), etc.
NeuroPace | 10-Q: Q3 2024 Earnings Report
NeuroPace | 8-K: NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
NeuroPace | SCHEDULE 13G: Others
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner KCK LTD.
NeuroPace | 144: Notice of proposed sale of securities pursuant to Rule 144
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner KCK LTD.
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner KCK LTD.
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner KCK LTD.
NeuroPace | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KCK Ltd.(19.0%)
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner KCK LTD.
NeuroPace | 144: Notice of proposed sale of securities pursuant to Rule 144
NeuroPace | 10-Q: Q2 2024 Earnings Report
NeuroPace | 8-K: NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Fischer Frank M
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Kumar Rakhi
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Andrade Lisa
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Ryan Renee
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Geiger Uri
Analysis
Price Target
No Data
No Data